Have you ever touched someone else and wondered why his or her skin felt so incredibly soft? Well, now researchers reporting in the Cell Press journal Current Biology on September 10 present evidence that this experience may often be an illusion. (more…)
Scientists are locked in a perpetual race with deadly bacteria, struggling to come up with new drugs as bacteria evolve new defenses. Corey Compton has demonstrated that a strategy focused on how bacteria develop resistance can give drugs — new and old — a leg up. (more…)
Last summer, after a long career as a successful entrepreneur and a brief retirement, Richard Whitaker was helping to start another new company. Unfortunately, a serious health concern caused a couple of interruptions in his work on the new venture. One of Whitaker’s heart valves wasn’t working properly, which caused congestive heart failure and led to two hospitalizations within several months. (more…)
Various sight recovery therapies are being developed by companies around the world, offering new hope for people who are blind. But little is known about what the world will look like to patients who undergo those procedures. (more…)
ANN ARBOR — Rationally speaking, most people know that random, violent crime is rare. But that doesn’t keep them from getting the creeps when they walk through a parking structure or other public place that’s not well-lit or crowded. (more…)
Freiburger Forscher entschlüsseln Mechanismen, mit denen Tumore bei Stress ihr eigenes Wachstum fördern
Ein Enzym, das Tumorwachstum fördert, sammelt sich in gestressten Krebszellen verstärkt an. Das hat die Gruppe des Freiburger Molekularmediziners Prof. Dr. Thomas Reinheckel zusammen mit der Freiburger Biochemikerin Prof. Dr. Sabine Rospert sowie mit Prof. Dr. Elmar Stickeler und Dr. Peter Bronsert vom Universitätsklinikum Freiburg herausgefunden. Das Team hat die Forschungsergebnisse in der Fachzeitschrift „Journal of Biological Chemistry“ veröffentlicht.
A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration. (more…)
ANN ARBOR — Employees seeking to boost their productivity at work should take a nap—yes, sleeping on the job can be a good thing. (more…)
